Since 2008, the CDC's Human Papillomavirus Vaccine Impact Monitoring Project has tracked trends in precancerous cervical lesions to evaluate the vaccine's effectiveness. The findings are striking.

Among women aged 20 to 24 years who were screened for cervical cancer, rates decreased by 79, 80 percent for CIN2+, CIN3+.

New trends data show significant reduction in the incidence of precancerous lesions in young women since advent of vaccine.

Cervical cancer remains one of the most preventable cancers, yet it continues to pose a significant health threat to women in ...

China has met its goal to raise the national cervical cancer screening rate above 50 percent ahead of schedule, but experts ...

A new CDC report finds that rates of precancerous lesions detected in women ages 20 to 24 have decreased by nearly 80%, lesions that would likely develop into cervical cancer years later.

“CDC has monitored incidence of precancerous lesions ... which are detected through cervical cancer screening and can be used as an intermediate outcome for monitoring vaccination ...

A CDC report shows a dramatic drop in precancerous HPV lesions in young women. Here’s why the HPV vaccine is beneficial.

New CDC data on falling rates of precancerous cervical lesions in the U.S. underscore the benefits of HPV vaccination.